Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    On July 8, 2010, Alcon's independent director committee (IDC) had set up a $50 million litigation trust to ensure company's minority shareholders get the best deal from bidder Novartis AG. [15] On April 9, 2019, Alcon completed a 100% spin-off from Novartis. [4] [16] [17] The new standalone company is worth up to 28 billion Swiss francs. [18]

  3. Novartis hands investors Alcon spin-off, $5 billion ... - AOL

    www.aol.com/news/novartis-hands-investors-alcon...

    Novartis plans to spin off its Alcon eye care business to shareholders and buy back up to $5 billion in stock as Chief Executive Vas Narasimhan refocuses the Swiss group on prescription drugs.

  4. Novartis to Spin-Off Alcon as Separate Trading Company - AOL

    www.aol.com/news/novartis-spin-off-alcon...

    Novartis announces that it will spin-off its ophthalmology division, Alcon, into a separately-traded standalone company in order to focus on its legacy pharmaceuticals business.

  5. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. [128] In April 2019, Novartis completed the spin-off of Alcon as a separate commercial entity. [73] Sandoz: As of 2013, Sandoz has been recognized as the world's second-largest generic drug company.

  6. Novartis' Sandoz dips on debut after lower than expected ...

    www.aol.com/news/novartis-completes-sandoz-spin...

    The debut made Sandoz the largest new entrant to the Swiss stock exchange since 2019, when another Novartis spin-off, eyecare company Alcon, was valued at about 28 billion francs.

  7. Gilead Sciences - Wikipedia

    en.wikipedia.org/wiki/Gilead_Sciences

    Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

  8. Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP ... - AOL

    www.aol.com/news/pharma-stock-roundup-nvs-divest...

    Novartis (NVS) intends to spin off its Alcon eye care division. The CHMP gives positive opinion recommending marketing approval to several drugs. Pharma Stock Roundup: NVS to Divest Eye Care Unit ...

  9. Swiss Market Index - Wikipedia

    en.wikipedia.org/wiki/Swiss_Market_Index

    Sika announced a 1:60 stock split. [22] Before this change, it was the SMI constituent with the highest price per share. April 2019: Julius Bär replaced by Alcon after a spin-off (5:1) from Novartis. [23] September 2020: Adecco replaced by Partners Group after the ordinary index review. [24] May 2021: LafargeHolcim renamed to Holcim. September ...